The Fraunhofer-Gesellschaft currently operates 76 institutes and research units throughout Germany and is a leading applied research organization. Around 32 000 employees work with an annual research budget of 3.4 billion euros.
At the Fraunhofer Institute of Interfacial and Biochemical Engineering IGB, we combine biology and technology in our business areas Health, Sustainable Chemistry, and Environmental and Climate protection. We develop processes, technologies and products for patient-focused healthcare, a sustainable bio-economy as well as a climate-neutral and resource-efficient circular economy and successfully transfer new solutions into industrial implementation. We conduct research at our locations in Stuttgart, Leuna, Straubing and Biberach as well as in close collaboration with numerous universities in Germany and abroad.
The Fraunhofer IGB is one of the 76 institutes and research centers of the Fraunhofer Society. Fraunhofer is the world's leading organization for application-oriented research. Approximately 32 000 employees work on an annual research volume of 3.4 billion euros.
Our »Virus-based Therapies and Technologies« department specializes in viral biotechnology and its enormous potential for applied research, from prokaryotic to eukaryotic viruses, and operates from two locations; the main institute in Stuttgart, and a newly established branch in Biberach. The department focuses on viral biotechnology and its enormous potential for applied research, from prokaryotic to eukaryotic viruses. The new Virus-based Therapies branch in Biberach, funded by the Baden-Württemberg Ministry of Economic Affairs, Labour and Tourism and located in the heart of the Biopharma Cluster South Germany, is dedicates to the development of biotechnological solutions for the production and analytics of viral therapeutics. It focuses on virus, cell and process technologies, in close collaboration with the local and regional partners of industrial and academic networks. The new unit acts as an interface between academia and industry with the main aim of enabling the cost-effective production of virus-based therapeutics thereby facilitating their clinical use in patients.
The vacancy is aimed at people with professional experience in research and development who are interested in contributing to the successful development of the department and in working in a highly specialized environment under excellent conditions in a field with major challenges and excellent future prospects.
APCT1_DE